Use of CryoStor® in Clinical Trials of New Regenerative Medicine Products & Therapies

Print Friendly
Clinical Indication Administration Route Reagent Status Pre-Clinical Phase I Phase II Phase III Approved
Disc Repair N/A Ancillary
Stroke N/A Ancillary
Malignant Glioma N/A Ancillary
Wound repair N/A Ancillary
Pediatric Blood Cancers Intravenous Excipient Hospital Practice of Medicine
Stress Urinary Incontinence Intraurethral Excipient
Multiple Sclerosis Subcutaneous Excipient
Amyotrophic Lateral Sclerosis N/A Ancillary
Hematologic Malignancies Intravenous Excipient
Sickle Cell Disease Intravenous Excipient
AMD Sub-retinal Excipient
Melanoma N/A Ancillary
Melanoma N/A Ancillary
Hematologic Malignancies Intravenous Excipient
Melanoma Intratumoral Excipient
Ischemic Heart Disease N/A Ancillary
Joint Disease Intra-articular Excipient
Prostate Cancer Subcutaneous Excipient
AML Intradermal Excipient
Joint Disease N/A Ancillary
CCALD Intravenous Excipient
PLIF/TLIF Intravertebral Excipient
Disc Repair Intravertebral Excipient
Metastatic Melanoma N/A Ancillary
Prostate Cancer Intradermal Excipient
Prostate Cancer Subcutaneous Excipient
AMI Intracoronary Excipient
Urea Cycle Disorders N/A Ancillary
HIV N/A Ancillary
Leukemias N/A Ancillary
Metastatic Melanoma N/A Ancillary
Acute Lymphoblastic Leukemia N/A Ancillary
Ovarian Cancer Subcutaneous Excipient
Ovarian Cancer Subcutaneous Excipient
Ovarian Cancer Subcutaneous Excipient
Radiation Injury N/A Ancillary
Urinary Sphincter Repair Intramuscular Excipient
Fecal Incontinence Intramuscular Excipient
Ischemic Heart Disease Intramuscular Excipient
Hematologic Malignancies Intravenous Excipient
Metastatic Melanoma N/A Ancillary
beta-thalassemia major Intravenous Excipient
Hematologic Malignancies N/A Ancillary
Treg Production N/A Ancillary
Organ Rejection N/A Ancillary
Non-Hodgkin Lymphoma N/A Ancillary
Occlusive Kidney Disease Intra-arterial Excipient
Metastatic Cancer N/A Ancillary
B Cell Malignancies N/A Ancillary
Metastatic Cancer N/A Ancillary
Malignant Glioma N/A Ancillary
Metastatic Cancer N/A Ancillary
GI Cancers N/A Ancillary
Metastatic Melanoma N/A Ancillary
Metastatic Melanoma N/A Ancillary
Advanced Melanoma N/A Ancillary
HPV Associated Cancers N/A Ancillary
Metastatic Ocular Melanoma N/A Ancillary
Joint Disease N/A Ancillary
Crohn’s Disease N/A Ancillary
Hypoplastic Left Heart Intracardiac Excipient
Non-Hodgkin Lymphoma Intratumoral Excipient
Ovarian Cancer N/A Ancillary
Glioblastoma Multiforme Intradermal Excipient
GVHD Intra-arterial Excipient
Multiple System Atrophy N/A Ancillary
Hematologic Malignancies Intravenous Excipient
DC Vaccine Production N/A Ancillary
Ischemic Stroke N/A Ancillary
AMI N/A Ancillary
Cutaneous Photoaging N/A Ancillary

 

Information deemed accurate as of September 3, 2013, as sourced from www.clinicaltrials.gov and direct customer communication. BioLife Solutions has no obligation to update this information. Please contact support@biolifesolutions.com if you have a question or comment about this information.